Donald W. Mann

Oclacitinib (<scp>APOQUEL</scp>^®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy

Andrea J. Gonzales, Jill Bowman, Gregory J. Fici et al. · Journal of Veterinary Pharmacology and Therapeutics · 2014 · 236 citations · Full text

5-Heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part 1: Structure–activity relationship studies of 5-alkylamino pyrazoles and discovery of a potent, selective, and orally active analog

Subas M. Sakya, Kristin M. Lundy DeMello, Martha L. Minich et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 51 citations · Full text

5-Alkylamino Pyrazoles, Molecular Pharmacology, Medicinal Chemistry +11

Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors

Hengmiao Cheng, Kristin M. Lundy DeMello, Jin Li et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 39 citations · Full text

Medicinal Chemistry, Medicine, Heteroaryl-phenyl-substituted Pyrazole Derivatives +9

Discovery of a potent, selective and orally active canine COX-2 inhibitor, 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl-pyridine

Jin Li, Kristin M. Lundy DeMello, Henry S. Cheng et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 38 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Medicine +7

5-Heteroatom-substituted pyrazoles as canine COX-2 inhibitors: Part 2. Structure–activity relationship studies of 5-alkylethers and 5-thioethers

Subas M. Sakya, Hengmiao Cheng, Kristin M. Lundy DeMello et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 34 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +11